Central Bank & Trust Co. Lowers Position in Intuitive Surgical, Inc. $ISRG

Central Bank & Trust Co. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% during the third quarter, Holdings Channel reports. The fund owned 15,336 shares of the medical equipment provider’s stock after selling 1,446 shares during the period. Intuitive Surgical makes up about 1.1% of Central Bank & Trust Co.’s holdings, making the stock its 27th biggest holding. Central Bank & Trust Co.’s holdings in Intuitive Surgical were worth $6,859,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Norway Savings Bank lifted its holdings in shares of Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares during the last quarter. Trust Co. of Oklahoma bought a new position in Intuitive Surgical during the 2nd quarter valued at approximately $363,000. IronOak Wealth LLC. purchased a new position in Intuitive Surgical during the second quarter valued at $1,099,000. Eastover Investment Advisors LLC boosted its holdings in Intuitive Surgical by 204.8% in the second quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock worth $7,153,000 after acquiring an additional 8,844 shares in the last quarter. Finally, Amalgamated Bank boosted its holdings in Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 22,806 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the sale, the insider directly owned 2,694 shares in the company, valued at approximately $1,537,977.66. The trade was a 89.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by corporate insiders.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Truist Financial lifted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research report on Thursday. Royal Bank Of Canada lifted their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, Piper Sandler increased their target price on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.08.

Intuitive Surgical Trading Up 1.9%

Shares of ISRG opened at $572.47 on Friday. The firm has a fifty day simple moving average of $541.48 and a two-hundred day simple moving average of $506.30. The firm has a market cap of $205.22 billion, a PE ratio of 75.72, a P/E/G ratio of 5.16 and a beta of 1.68. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period last year, the business posted $1.84 EPS. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.